JOHNSON & JOHNSON Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Johnson & Johnson quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Johnson & Johnson Income Tax Expense (Benefit) for the quarter ending September 29, 2024 was $644M, a 29.1% decline year-over-year.
  • Johnson & Johnson Income Tax Expense (Benefit) for the twelve months ending September 29, 2024 was $2.86B, a 99.9% increase year-over-year.
  • Johnson & Johnson annual Income Tax Expense (Benefit) for 2023 was $1.74B, a 41.9% decline from 2022.
  • Johnson & Johnson annual Income Tax Expense (Benefit) for 2022 was $2.99B, a 117% increase from 2021.
  • Johnson & Johnson annual Income Tax Expense (Benefit) for 2021 was $1.38B, a 22.8% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.86B $644M -$264M -29.1% Jul 1, 2024 Sep 29, 2024 10-Q 2024-10-23
Q2 2024 $3.12B $1.06B +$132M +14.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $2.99B $459M +$1.26B Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.74B $694M +$306M +78.9% Oct 2, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $1.43B $908M +$46M +5.34% Jul 3, 2023 Oct 1, 2023 10-Q 2024-10-23
Q2 2023 $1.38B $930M -$96M -9.36% Apr 3, 2023 Jul 2, 2023 10-Q 2024-07-25
Q1 2023 $1.48B -$796M -$1.51B -212% Jan 2, 2023 Apr 2, 2023 10-Q 2024-05-01
Q4 2022 $2.99B $388M +$809M Oct 3, 2022 Jan 1, 2023 10-K 2024-02-16
Q3 2022 $2.18B $862M +$680M +374% Jul 4, 2022 Oct 2, 2022 10-Q 2023-10-27
Q2 2022 $1.5B $1.03B +$642M +167% Apr 4, 2022 Jul 3, 2022 10-Q 2023-07-31
Q1 2022 $858M $713M -$519M -42.1% Jan 3, 2022 Apr 3, 2022 10-Q 2023-04-28
Q4 2021 $1.38B -$421M -$330M -363% Oct 4, 2021 Jan 2, 2022 10-K 2024-02-16
Q3 2021 $1.71B $182M -$665M -78.5% Jul 5, 2021 Oct 3, 2021 10-Q 2022-10-27
Q2 2021 $2.37B $384M +$70M +22.3% Apr 5, 2021 Jul 4, 2021 10-Q 2022-07-29
Q1 2021 $2.3B $1.23B +$519M +72.8% Jan 4, 2021 Apr 4, 2021 10-Q 2022-04-29
Q4 2020 $1.78B -$91M -$299M -144% Sep 28, 2020 Jan 3, 2021 10-K 2023-02-16
Q3 2020 $2.08B $847M +$953M Jun 29, 2020 Sep 27, 2020 10-Q 2021-10-29
Q2 2020 $1.13B $314M -$1.12B -78.1% Mar 30, 2020 Jun 28, 2020 10-Q 2021-07-29
Q1 2020 $2.25B $713M +$40M +5.94% Dec 30, 2019 Mar 29, 2020 10-Q 2021-04-30
Q4 2019 $2.21B $208M +$128M +160% Sep 30, 2019 Dec 29, 2019 10-K 2022-02-17
Q3 2019 $2.08B -$106M -$595M -122% Jul 1, 2019 Sep 29, 2019 10-Q 2020-10-23
Q2 2019 $2.68B $1.43B +$415M +40.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 $2.26B $673M -$441M -39.6% Dec 31, 2018 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $2.7B $80M -$13.2B -99.4% Oct 1, 2018 Dec 30, 2018 10-K 2021-02-22
Q3 2018 $15.9B $489M -$537M -52.3% Jul 2, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $16.4B $1.02B +$98M +10.6% Apr 2, 2018 Jul 1, 2018 10-Q 2019-07-29
Q1 2018 $16.3B $1.11B -$39M -3.38% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-01
Q4 2017 $16.4B $13.3B +$12.8B +2503% Oct 2, 2017 Dec 31, 2017 10-K 2020-02-18
Q3 2017 $3.61B $1.03B +$17M +1.69% Jul 3, 2017 Oct 1, 2017 10-Q 2018-10-31
Q2 2017 $3.59B $921M +$14M +1.54% Apr 3, 2017 Jul 2, 2017 10-Q 2018-08-02
Q1 2017 $3.58B $1.15B +$316M +37.8% Jan 2, 2017 Apr 2, 2017 10-Q 2018-05-01
Q4 2016 $3.26B $510M -$33M -6.08% Oct 3, 2016 Jan 1, 2017 10-K 2019-02-20
Q3 2016 $3.3B $1.01B +$245M +32.1% Jul 4, 2016 Oct 2, 2016 10-Q 2017-11-02
Q2 2016 $3.05B $907M -$318M -26% Apr 4, 2016 Jul 3, 2016 10-Q 2017-08-03
Q1 2016 $3.37B $837M -$418M -33.3% Jan 4, 2016 Apr 3, 2016 10-Q 2017-05-08
Q4 2015 $3.79B $543M +$361M +198% Sep 28, 2015 Jan 3, 2016 10-K 2018-02-21
Q3 2015 $3.43B $764M -$1.3B -62.9% Jun 29, 2015 Sep 27, 2015 10-Q 2016-11-04
Q2 2015 $4.72B $1.23B -$75M -5.77% Mar 30, 2015 Jun 28, 2015 10-Q 2016-08-04
Q1 2015 $4.8B $1.26B +$558M +80.1% Dec 29, 2014 Mar 29, 2015 10-Q 2016-05-10
Q4 2014 $4.24B $182M +$951M Sep 29, 2014 Dec 28, 2014 10-K 2017-02-27
Q3 2014 $3.29B $2.06B +$1.38B +201% Jun 30, 2014 Sep 28, 2014 10-Q 2015-10-30
Q2 2014 $1.91B $1.3B +$340M +35.4% Mar 31, 2014 Jun 29, 2014 10-Q 2015-07-31
Q1 2014 $1.57B $697M -$67M -8.77% Dec 30, 2013 Mar 30, 2014 10-Q 2015-05-01
Q4 2013 $1.64B -$769M -$1.3B -244% Sep 30, 2013 Dec 29, 2013 10-K 2016-02-24
Q3 2013 $2.94B $685M -$281M -29.1% Jul 1, 2013 Sep 29, 2013 10-Q 2014-10-30
Q2 2013 $3.22B $960M +$333M +53.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $2.89B $764M -$371M -32.7% Dec 31, 2012 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $3.26B $533M +$433M +433% Oct 1, 2012 Dec 30, 2012 10-K 2015-02-24
Q3 2012 $2.83B $966M +$57M +6.27% Jul 2, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $2.77B $627M -$19M -2.94% Apr 2, 2012 Jul 1, 2012 10-Q 2013-08-01
Q1 2012 $2.79B $1.14B +$101M +9.77% Jan 2, 2012 Apr 1, 2012 10-Q 2013-05-03
Q4 2011 $2.69B $100M -$186M -65% Oct 3, 2011 Jan 1, 2012 10-K 2014-02-21
Q3 2011 $2.88B $909M +$107M +13.3% Jul 4, 2011 Oct 2, 2011 10-Q 2012-11-09
Q2 2011 $2.77B $646M -$125M -16.2% Apr 4, 2011 Jul 3, 2011 10-Q 2012-08-02
Q1 2011 $2.89B $1.03B -$720M -41% Jan 3, 2011 Apr 3, 2011 10-Q 2012-05-07
Q4 2010 $3.61B $286M Oct 4, 2010 Jan 2, 2011 10-K 2013-02-22
Q3 2010 $802M Jul 5, 2010 Oct 3, 2010 10-Q 2011-11-08
Q2 2010 $771M Apr 5, 2010 Jul 4, 2010 10-Q 2011-08-09
Q1 2010 $1.75B Jan 4, 2010 Apr 4, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.